IP Library Granted Patent US 7,741,471
Granted Patent B2
US 7,741,471 · App. 11/915,279 · Granted Jun 22, 2010

Reagents for the improved synthesis of isoguanosine containing oligonucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,471
App. No.
11/915,279
Granted
Jun 22, 2010
Kind
B2
Abstract

The present invention provides the combination of the O-2 diphenylcarbamoyl (“DPC”) and N-6 dimethylaminomethylidene (“DMF”) protecting groups for isoguanosine nucleosides that can be utilized in oligonucleotide synthesis.

Claims (19)

1. A compound of the formula:

2. A compound of the formula:

wherein

E is an acid labile protecting group;

A is an O-phosphoramidite protecting group orthogonal to E;

D is NT 1 T 2 wherein

T 1 and T 2 are each, independently, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted aralkyl group; or

T 1 and T 2 taken together with the nitrogen to which they are bonded form a heterocycloalkyl group or a herteroaromatic group; and

G 1 and G 2 are substituted or unsubstituted hydrocarbon radicals.

3. The compound of claim 2 wherein E is a substituted trityl or pixyl.

4. The compound of claim 2 wherein A is, independently, cyanoethyl, a substituted or unsubstituted aliphatic group, or a substituted or unsubstituted aromatic group.

5. The compound of claim 2 wherein G 1 and G 2 are each a phenyl group.

6. The compound of claim 2 wherein E is 4′,4-dimethoxytrityl.

7. The compound of claim 2 wherein A is cyanoethyl.

8. The compound of claim 2 wherein T 1 and T 2 is an isopropyl group.

9. The compound of claim 2 wherein T 1 and T 2 are each independently a substituted or unsubstituted aliphatic group.

10. The compound of claim 9 wherein T 1 and T 2 are each independently a lower alkyl group.

11. The compound of claim 2 wherein G 1 and G 2 are each independently a substituted or unsubstituted aliphatic or aromatic monovalent, or, when taken together, divalent radical, having from one to 20 carbon atoms.

12. The compound of claim 11 wherein G 1 and G 2 are each a substituted or unsubstituted aromatic group.

Assignments (2)
MERGER Recorded Jun 21, 2012
From: ERAGEN BIOSCIENCES, INC.
To: LUMINEX CORPORATION
Reel/Frame 028420/0945 →
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2011
From: SILICON VALLEY BANK
To: ERAGEN BIOSCIENCES, INC.
Reel/Frame 026561/0510 →